Advisory Alpha, LLC Amgen Inc Transaction History

Advisory Alpha, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $21,205 - $25,251	-98 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$234.65 - $260.95 $22,995 - $25,573	98 New	98 $1.03 Million
Q1 2020 Apr 29, 2020	SELL	$182.24 - $241.7 $18,770 - $24,895	-103 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $12,677 - $16,294	-67 Reduced 39.41%	103 $24.4 Million
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $29,598 - $35,465	170 New	170 $32,000
Q2 2019 Aug 16, 2019	SELL	$166.7 - $195.41 $9,835 - $11,529	-59 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $10,671 - $12,028	59 New	59 $0

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Advisory Alpha, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Alpha, LLC with notifications on news.